Qiagen (QGEN) News Today $46.00 +0.10 (+0.21%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Qiagen (NYSE:QGEN) Sees Large Decline in Short InterestQiagen (NYSE:QGEN - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 3,060,000 shares, a decline of 18.0% from the December 15th total of 3,730,000 shares. Based on an average trading volume of 864,900 shares, the days-to-cover ratio is currently 3.5 days. Currently, 1.4% of the shares of the company are sold short.January 17 at 8:16 AM | marketbeat.comQiagen (QGEN) Gets a Hold from Kepler CapitalJanuary 16 at 9:50 PM | markets.businessinsider.comQiagen NV Announces Completion of $300 Million Synthetic Share Repurchase PlanJanuary 16 at 5:31 PM | gurufocus.comQIAGEN Finalizes $300 Million Synthetic Share Repurchase PlanJanuary 16 at 5:31 PM | tipranks.comQIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 MillionJanuary 16 at 4:05 PM | businesswire.comBeiGene (ONC) Moves 8.9% Higher: Will This Strength Last?January 15 at 1:14 PM | msn.comQIAGEN N.V. to Release Results for Q4 2024 and Hold WebcastJanuary 15 at 1:14 PM | finance.yahoo.comBuy Rating for Qiagen: Strategic Financial Moves and Growth Potential HighlightedJanuary 13, 2025 | markets.businessinsider.comHold Rating on Qiagen: Balancing Stock Buyback Benefits with Strategic Growth ExecutionJanuary 13, 2025 | markets.businessinsider.comQIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share RepurchaseJanuary 12, 2025 | gurufocus.comQiagen NV Announces $300 Million Synthetic Share Repurchase PlanJanuary 12, 2025 | gurufocus.comQIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share RepurchaseJanuary 12, 2025 | businesswire.comQiagen Gets U.S. Clearance for Gastrointestinal-Illness TestJanuary 10, 2025 | marketwatch.comQIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient careJanuary 10, 2025 | stockhouse.comQiagen secures U.S. clearance for QIAstat-Dx mini gastrointestinal panelJanuary 10, 2025 | markets.businessinsider.comQiagen Gets U.S. Regulatory Clearance For QIAstat-Dx Gastrointestinal Panel TestsJanuary 10, 2025 | markets.businessinsider.comQiagen Announces BlackRock’s Significant Stake in CompanyJanuary 10, 2025 | tipranks.comQiagen NV (QGEN) Enhances QIAcuity Digital PCR System with Advanced Multiplexing CapabilitiesJanuary 10, 2025 | gurufocus.comQIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological SamplesJanuary 10, 2025 | businesswire.comQiagen NV (QGEN) Gains FDA Clearance for QIAstat-Dx Gastrointestinal PanelJanuary 9, 2025 | gurufocus.comQiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from AnalystsQiagen (NYSE:QGEN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine research firms that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year tJanuary 9, 2025 | marketbeat.comBlackRock’s Significant Stake Announcement in QiagenJanuary 9, 2025 | markets.businessinsider.comQiagen N.V. Announces Major Shareholder Voting Rights UpdateJanuary 9, 2025 | markets.businessinsider.comQIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic ContentJanuary 7, 2025 | businesswire.comMorgan Stanley Downgrades Qiagen N.V. (QGEN)January 7, 2025 | msn.comMorgan Stanley upgrades European medtech stocks to attractiveJanuary 6, 2025 | investing.comQiagen (NYSE:QGEN) Given Equal Weight Rating at Morgan StanleyMorgan Stanley reissued an "equal weight" rating and set a $48.00 target price (down from $50.00) on shares of Qiagen in a research report on Monday.January 6, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 424,937 Shares of Qiagen (NYSE:QGEN)JPMorgan Chase & Co. boosted its position in shares of Qiagen (NYSE:QGEN - Free Report) by 36.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,604,034 shares of the company's stock after purchasing an additional 424,937 shares during theJanuary 4, 2025 | marketbeat.comQiagen N.V. Discloses BlackRock’s Voting Rights NotificationJanuary 3, 2025 | tipranks.comBlackRock Increases Voting Influence in QiagenDecember 31, 2024 | markets.businessinsider.comWhy Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?December 30, 2024 | msn.comFranklin Resources Inc. Has $3.86 Million Stake in Qiagen (NYSE:QGEN)Franklin Resources Inc. reduced its position in shares of Qiagen (NYSE:QGEN - Free Report) by 33.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,470 shares of the company's stock after sellingDecember 25, 2024 | marketbeat.comGeode Capital Management LLC Sells 42,127 Shares of Qiagen (NYSE:QGEN)Geode Capital Management LLC lessened its position in Qiagen (NYSE:QGEN - Free Report) by 3.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,055,671 shares of the company's stock after selling 42,127 sharDecember 24, 2024 | marketbeat.comQiagen Highlights BlackRock’s Indirect Stake in Voting Rights DisclosureDecember 20, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT) and Qiagen (QGEN)December 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Lemaitre Vascular (LMAT)December 17, 2024 | markets.businessinsider.comState Street Corp Raises Stock Holdings in Qiagen (NYSE:QGEN)State Street Corp boosted its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 3.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,380,008 shares of the company's stock after acquiring an additionDecember 16, 2024 | marketbeat.comQiagen (NYSE:QGEN) Receives Average Recommendation of "Moderate Buy" from AnalystsQiagen (NYSE:QGEN - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten brokerages that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The averagDecember 15, 2024 | marketbeat.comQiagen launches AI-extension of Ingenuity Pathway AnalysisDecember 14, 2024 | markets.businessinsider.comQiagen NV (QGEN) Launches AI-Driven IPA Interpret for Enhanced Biological Data AnalysisDecember 12, 2024 | gurufocus.comQIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological DataDecember 12, 2024 | businesswire.comBarclays PLC Acquires 1,165,594 Shares of Qiagen (NYSE:QGEN)Barclays PLC grew its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 170.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,849,004 shares of the company's stock after acquiring an additionalDecember 12, 2024 | marketbeat.com214,400 Shares in Qiagen (NYSE:QGEN) Bought by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio bought a new stake in Qiagen (NYSE:QGEN - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 214,400 shares of the company's sDecember 12, 2024 | marketbeat.comQiagen assumed with Buy from Hold at JefferiesDecember 11, 2024 | markets.businessinsider.comXTX Topco Ltd Purchases 11,385 Shares of Qiagen (NYSE:QGEN)XTX Topco Ltd raised its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 129.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,192 shares of the company's stock after purchasing an additional 11,December 11, 2024 | marketbeat.comQiagen (NYSE:QGEN) Earns Buy Rating from Jefferies Financial GroupJefferies Financial Group restated a "buy" rating and issued a $54.00 target price (up from $42.00) on shares of Qiagen in a report on Tuesday.December 10, 2024 | marketbeat.comPoint72 Asset Management L.P. Trims Stock Position in Qiagen (NYSE:QGEN)Point72 Asset Management L.P. cut its position in Qiagen (NYSE:QGEN - Free Report) by 96.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,439 shares of the company's stock after selling 1,138,3December 10, 2024 | marketbeat.comQiagen (NYSE:QGEN) Stock Position Cut by Janus Henderson Group PLCJanus Henderson Group PLC decreased its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 70.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 126,059 shares of the company's stock after selling 304,687December 10, 2024 | marketbeat.comQiagen (NYSE:QGEN) Shares Acquired by Quantinno Capital Management LPQuantinno Capital Management LP boosted its holdings in Qiagen (NYSE:QGEN - Free Report) by 31.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 78,707 shares of the company's stock after buying an additional 18,716 shares during the quarDecember 9, 2024 | marketbeat.comVerition Fund Management LLC Takes $1.17 Million Position in Qiagen (NYSE:QGEN)Verition Fund Management LLC bought a new stake in shares of Qiagen (NYSE:QGEN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 25,658 shares of the company's stock, valued at approximately $1,16December 8, 2024 | marketbeat.com Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address QGEN Media Mentions By Week QGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QGEN News Sentiment▼0.730.72▲Average Medical News Sentiment QGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QGEN Articles This Week▼136▲QGEN Articles Average Week Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News BNTX News TEVA News BGNE News GMAB News VTRS News ITCI News SMMT News MRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:QGEN) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.